Safety evaluation of the excessive intake of

Bacillus subtilis C-3102 Bone mineral density Excessive intake Gut microbiota Safety evaluation

Journal

Toxicology reports
ISSN: 2214-7500
Titre abrégé: Toxicol Rep
Pays: Ireland
ID NLM: 101630272

Informations de publication

Date de publication:
2020
Historique:
received: 17 12 2018
revised: 11 11 2019
accepted: 13 11 2019
entrez: 28 12 2019
pubmed: 28 12 2019
medline: 28 12 2019
Statut: epublish

Résumé

Continuous intake of A total of 69 individuals provided an informed consent, and 44 subjects who met the inclusion criteria were allocated to either the The final analysis included data from 22 subjects (9 men, 13 women; age, 46.1 ± 13.8 years) in the C-3102 group and 22 subjects (9 men, 13 women; age, 46.1 ± 13.5 years) in the P group. The results revealed no medical-related problems in both C-3102 and P groups. This study proved the safety of 4-week continuous consumption of an excessive amount of

Identifiants

pubmed: 31879597
doi: 10.1016/j.toxrep.2019.11.009
pii: S2214-7500(18)30760-1
pmc: PMC6920086
doi:

Types de publication

Journal Article

Langues

eng

Pagination

46-58

Informations de copyright

© 2019 The Authors.

Déclaration de conflit d'intérêts

This study was sponsored by the following companies: Asahi Calpis Wellness Co., Ltd funded the study implementation and manuscript writing. M. H., H. K., R. T., I. N., and M. Y. are members of Asahi Calpis Wellness Co., Ltd. that entrusted ORTHOMEDICO, Inc. T. H. and S. I., who are members of ORTHOMEDICO Inc., were involved in the planning of the study, the study implementation, and manuscript writing. The study was conducted by both Asahi Calpis Wellness Co., Ltd and ORTHOMEDICO Inc. Furthermore, T. T. (MD) is the principal investigator who monitors all subjects’ conditions.

Références

BMC Microbiol. 2016 May 25;16:90
pubmed: 27220822
Nature. 2010 Mar 4;464(7285):59-65
pubmed: 20203603
Hypertens Res. 2014 Apr;37(4):253-390
pubmed: 24705419
Benef Microbes. 2018 Apr 25;9(3):357-365
pubmed: 29482338
Front Neurosci. 2017 Sep 15;11:490
pubmed: 28966571
Nihon Naika Gakkai Zasshi. 2001 Jul 10;90(7):1199-206
pubmed: 11519095
Sci Rep. 2017 Sep 7;7(1):10776
pubmed: 28883460
Biosci Microbiota Food Health. 2018;37(4):87-96
pubmed: 30370192
Nature. 2016 Jul 06;535(7610):56-64
pubmed: 27383980

Auteurs

Misaki Hatanaka (M)

ASAHI CALPIS WELLNESS Co., Ltd., 2-4-1 Ebisuminami, Shibuya-ku, Tokyo 150-0022, Japan.

Hiroki Kanzato (H)

ASAHI CALPIS WELLNESS Co., Ltd., 2-4-1 Ebisuminami, Shibuya-ku, Tokyo 150-0022, Japan.

Ryoko Tsuda (R)

ASAHI CALPIS WELLNESS Co., Ltd., 2-4-1 Ebisuminami, Shibuya-ku, Tokyo 150-0022, Japan.

Isao Nadaoka (I)

ASAHI CALPIS WELLNESS Co., Ltd., 2-4-1 Ebisuminami, Shibuya-ku, Tokyo 150-0022, Japan.

Masaaki Yasue (M)

ASAHI CALPIS WELLNESS Co., Ltd., 2-4-1 Ebisuminami, Shibuya-ku, Tokyo 150-0022, Japan.

Tomohiro Hoshino (T)

ORTHOMEDICO Inc., 2 F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, 112-0002, Japan.

Shin-Ichiro Iio (SI)

ORTHOMEDICO Inc., 2 F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, 112-0002, Japan.

Tsuyoshi Takara (T)

Medical Corporation Seishinkai, Takara Clinic, 9F Taisei Building, 2-3-2, Higashi-gotanda, Shinagawa-ku, Tokyo, 141-0022, Japan.

Classifications MeSH